Your session is about to expire
← Back to Search
REGN1908-1909 for Rhinitis
Study Summary
This trial is testing a new drug to see if it can help people with allergies to cats by reducing symptoms and the need for rescue medication. The study will also look at the safety and tolerability of the drug.
- Cat Allergy Rhinitis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 56 Patients • NCT03838731Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any risks to using REGN1908-1909?
"REGN1908-1909's safety is based on its Phase 3 status, meaning that there is both efficacy and safety data supporting its use."
Are there a few research facilities in Canada that are conducting this investigation?
"At the moment, this trial is open to patients at 100 different sites. Some of these locations include Greenfield and New york; however, there are many other sites that are located near you. To limit the amount of travel needed, please select the site closest to your location."
Are there any openings in this clinical research for new participants?
"Yes, the most recent information hosted on clinicaltrials.gov indicates that this study is looking for more participants. This particular clinical trial was posted on 7/30/2021 and was last updated 9/2/2022. In total, they are looking for 630 people to participate across 100 different locations."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger